{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-154095","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2022-05-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.977672+00:00","generated_at":"2026-06-25T09:46:51.034315+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Bio-Rad updates share repurchase activity: $125M repurchased QTD","bullets":["Quarter-to-date through May 17, 2022, Bio-Rad repurchased $125M of Class A common stock.","Repurchased 255k shares at an average price of $489.65 per share.","Total repurchased under program: $351.9M; remaining authorization: $98.1M.","Buyback program authorized Nov 2017 for $250M, increased by $200M in July 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-154095","json":"https://secwatch.observer/filing/0001193125-22-154095.json","markdown":"https://secwatch.observer/filing/0001193125-22-154095.md","text":"https://secwatch.observer/filing/0001193125-22-154095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000119312522154095/0001193125-22-154095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000119312522154095/d355304d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T09:46:51.034315+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}